nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—ADRB1—dilated cardiomyopathy	0.433	0.543	CbGaD
Propranolol—ADRB2—dilated cardiomyopathy	0.364	0.457	CbGaD
Propranolol—ABCB1—Lisinopril—dilated cardiomyopathy	0.024	0.532	CbGbCtD
Propranolol—ABCB1—Spironolactone—dilated cardiomyopathy	0.0211	0.468	CbGbCtD
Propranolol—Central nervous system disorder—Furosemide—dilated cardiomyopathy	0.00807	0.0824	CcSEcCtD
Propranolol—Hypersomnia—Lisinopril—dilated cardiomyopathy	0.00466	0.0475	CcSEcCtD
Propranolol—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00389	0.0397	CcSEcCtD
Propranolol—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00293	0.0298	CcSEcCtD
Propranolol—Lethargy—Spironolactone—dilated cardiomyopathy	0.00221	0.0225	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00195	0.0199	CcSEcCtD
Propranolol—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00172	0.0176	CcSEcCtD
Propranolol—Throat sore—Lisinopril—dilated cardiomyopathy	0.00169	0.0172	CcSEcCtD
Propranolol—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00167	0.0171	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00165	0.0168	CcSEcCtD
Propranolol—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00155	0.0159	CcSEcCtD
Propranolol—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00145	0.0148	CcSEcCtD
Propranolol—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00141	0.0144	CcSEcCtD
Propranolol—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00134	0.0136	CcSEcCtD
Propranolol—Alopecia—Spironolactone—dilated cardiomyopathy	0.00132	0.0135	CcSEcCtD
Propranolol—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00131	0.0134	CcSEcCtD
Propranolol—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00125	0.0127	CcSEcCtD
Propranolol—Purpura—Furosemide—dilated cardiomyopathy	0.00122	0.0124	CcSEcCtD
Propranolol—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00122	0.0124	CcSEcCtD
Propranolol—Lethargy—Furosemide—dilated cardiomyopathy	0.0012	0.0122	CcSEcCtD
Propranolol—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00119	0.0122	CcSEcCtD
Propranolol—Irritability—Furosemide—dilated cardiomyopathy	0.00112	0.0115	CcSEcCtD
Propranolol—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00109	0.0111	CcSEcCtD
Propranolol—Indecainide—SCN5A—dilated cardiomyopathy	0.00108	0.0887	CrCbGaD
Propranolol—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00106	0.0108	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00106	0.0108	CcSEcCtD
Propranolol—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00102	0.0104	CcSEcCtD
Propranolol—Somnolence—Spironolactone—dilated cardiomyopathy	0.000945	0.00964	CcSEcCtD
Propranolol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000917	0.00936	CcSEcCtD
Propranolol—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000912	0.0093	CcSEcCtD
Propranolol—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000904	0.00922	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000899	0.00917	CcSEcCtD
Propranolol—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000846	0.00863	CcSEcCtD
Propranolol—Urticaria—Spironolactone—dilated cardiomyopathy	0.000844	0.00861	CcSEcCtD
Propranolol—Irritability—Lisinopril—dilated cardiomyopathy	0.000842	0.00859	CcSEcCtD
Propranolol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00084	0.00857	CcSEcCtD
Propranolol—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000839	0.00856	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000795	0.00811	CcSEcCtD
Propranolol—Visual impairment—Furosemide—dilated cardiomyopathy	0.000784	0.008	CcSEcCtD
Propranolol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000783	0.00799	CcSEcCtD
Propranolol—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000769	0.00785	CcSEcCtD
Propranolol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00075	0.00765	CcSEcCtD
Propranolol—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000734	0.00748	CcSEcCtD
Propranolol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000727	0.00742	CcSEcCtD
Propranolol—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000713	0.00727	CcSEcCtD
Propranolol—Erythema—Furosemide—dilated cardiomyopathy	0.000708	0.00722	CcSEcCtD
Propranolol—Ranolazine—SCN5A—dilated cardiomyopathy	0.000708	0.0583	CrCbGaD
Propranolol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000703	0.00717	CcSEcCtD
Propranolol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000703	0.00717	CcSEcCtD
Propranolol—Carvedilol—GJA1—dilated cardiomyopathy	0.00068	0.056	CrCbGaD
Propranolol—Carvedilol—NPPB—dilated cardiomyopathy	0.00068	0.056	CrCbGaD
Propranolol—Depression—Lisinopril—dilated cardiomyopathy	0.000678	0.00692	CcSEcCtD
Propranolol—Vomiting—Spironolactone—dilated cardiomyopathy	0.000676	0.00689	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000674	0.00688	CcSEcCtD
Propranolol—Rash—Spironolactone—dilated cardiomyopathy	0.00067	0.00683	CcSEcCtD
Propranolol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000669	0.00683	CcSEcCtD
Propranolol—Agitation—Furosemide—dilated cardiomyopathy	0.000651	0.00664	CcSEcCtD
Propranolol—Vertigo—Furosemide—dilated cardiomyopathy	0.000636	0.00649	CcSEcCtD
Propranolol—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000635	0.00647	CcSEcCtD
Propranolol—Nausea—Spironolactone—dilated cardiomyopathy	0.000631	0.00644	CcSEcCtD
Propranolol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000622	0.00634	CcSEcCtD
Propranolol—Hallucination—Lisinopril—dilated cardiomyopathy	0.000607	0.0062	CcSEcCtD
Propranolol—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000606	0.00618	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000599	0.00611	CcSEcCtD
Propranolol—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000578	0.0059	CcSEcCtD
Propranolol—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000577	0.00589	CcSEcCtD
Propranolol—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000567	0.00578	CcSEcCtD
Propranolol—Skin disorder—Furosemide—dilated cardiomyopathy	0.000562	0.00573	CcSEcCtD
Propranolol—Alopecia—Lisinopril—dilated cardiomyopathy	0.00054	0.0055	CcSEcCtD
Propranolol—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000535	0.00546	CcSEcCtD
Propranolol—Erythema—Lisinopril—dilated cardiomyopathy	0.000532	0.00542	CcSEcCtD
Propranolol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000519	0.00529	CcSEcCtD
Propranolol—Somnolence—Furosemide—dilated cardiomyopathy	0.000514	0.00524	CcSEcCtD
Propranolol—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000503	0.00513	CcSEcCtD
Propranolol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000499	0.00509	CcSEcCtD
Propranolol—Fatigue—Furosemide—dilated cardiomyopathy	0.000498	0.00508	CcSEcCtD
Propranolol—Pain—Furosemide—dilated cardiomyopathy	0.000494	0.00504	CcSEcCtD
Propranolol—Constipation—Furosemide—dilated cardiomyopathy	0.000494	0.00504	CcSEcCtD
Propranolol—Vertigo—Lisinopril—dilated cardiomyopathy	0.000478	0.00487	CcSEcCtD
Propranolol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000473	0.00482	CcSEcCtD
Propranolol—Cough—Lisinopril—dilated cardiomyopathy	0.000464	0.00473	CcSEcCtD
Propranolol—Urticaria—Furosemide—dilated cardiomyopathy	0.000459	0.00468	CcSEcCtD
Propranolol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000457	0.00466	CcSEcCtD
Propranolol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000457	0.00466	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000449	0.00458	CcSEcCtD
Propranolol—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000434	0.00442	CcSEcCtD
Propranolol—Infection—Lisinopril—dilated cardiomyopathy	0.000431	0.0044	CcSEcCtD
Propranolol—Practolol—ADRB1—dilated cardiomyopathy	0.000429	0.0353	CrCbGaD
Propranolol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000426	0.00434	CcSEcCtD
Propranolol—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000421	0.0043	CcSEcCtD
Propranolol—Asthenia—Furosemide—dilated cardiomyopathy	0.000415	0.00423	CcSEcCtD
Propranolol—Levobunolol—ADRB1—dilated cardiomyopathy	0.000406	0.0334	CrCbGaD
Propranolol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000396	0.00403	CcSEcCtD
Propranolol—Insomnia—Lisinopril—dilated cardiomyopathy	0.000392	0.004	CcSEcCtD
Propranolol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00039	0.00397	CcSEcCtD
Propranolol—Propafenone—SCN5A—dilated cardiomyopathy	0.000388	0.0319	CrCbGaD
Propranolol—Metipranolol—ADRB1—dilated cardiomyopathy	0.000388	0.0319	CrCbGaD
Propranolol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000387	0.00394	CcSEcCtD
Propranolol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000386	0.00393	CcSEcCtD
Propranolol—Dizziness—Furosemide—dilated cardiomyopathy	0.000382	0.0039	CcSEcCtD
Propranolol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000382	0.00389	CcSEcCtD
Propranolol—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000377	0.00385	CcSEcCtD
Propranolol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000374	0.00382	CcSEcCtD
Propranolol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000374	0.00381	CcSEcCtD
Propranolol—Constipation—Lisinopril—dilated cardiomyopathy	0.000371	0.00378	CcSEcCtD
Propranolol—Pain—Lisinopril—dilated cardiomyopathy	0.000371	0.00378	CcSEcCtD
Propranolol—Vomiting—Furosemide—dilated cardiomyopathy	0.000368	0.00375	CcSEcCtD
Propranolol—Rash—Furosemide—dilated cardiomyopathy	0.000365	0.00372	CcSEcCtD
Propranolol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000364	0.00371	CcSEcCtD
Propranolol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000355	0.00362	CcSEcCtD
Propranolol—Carteolol—ADRB1—dilated cardiomyopathy	0.000345	0.0284	CrCbGaD
Propranolol—Urticaria—Lisinopril—dilated cardiomyopathy	0.000345	0.00351	CcSEcCtD
Propranolol—Nausea—Furosemide—dilated cardiomyopathy	0.000343	0.0035	CcSEcCtD
Propranolol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000343	0.0035	CcSEcCtD
Propranolol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000343	0.0035	CcSEcCtD
Propranolol—Levobunolol—ADRB2—dilated cardiomyopathy	0.000342	0.0281	CrCbGaD
Propranolol—Metipranolol—ADRB2—dilated cardiomyopathy	0.000326	0.0268	CrCbGaD
Propranolol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00032	0.00326	CcSEcCtD
Propranolol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000311	0.00317	CcSEcCtD
Propranolol—Esmolol—ADRB1—dilated cardiomyopathy	0.000308	0.0253	CrCbGaD
Propranolol—Bevantolol—ADRB1—dilated cardiomyopathy	0.000304	0.025	CrCbGaD
Propranolol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000297	0.00303	CcSEcCtD
Propranolol—Carteolol—ADRB2—dilated cardiomyopathy	0.000291	0.0239	CrCbGaD
Propranolol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000287	0.00293	CcSEcCtD
Propranolol—Bopindolol—ADRB1—dilated cardiomyopathy	0.000282	0.0232	CrCbGaD
Propranolol—Vomiting—Lisinopril—dilated cardiomyopathy	0.000276	0.00281	CcSEcCtD
Propranolol—Rash—Lisinopril—dilated cardiomyopathy	0.000274	0.00279	CcSEcCtD
Propranolol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000273	0.00279	CcSEcCtD
Propranolol—Betaxolol—ADRB1—dilated cardiomyopathy	0.000271	0.0223	CrCbGaD
Propranolol—Atenolol—ADRB1—dilated cardiomyopathy	0.000269	0.0221	CrCbGaD
Propranolol—Penbutolol—ADRB1—dilated cardiomyopathy	0.000269	0.0221	CrCbGaD
Propranolol—Bisoprolol—ADRB1—dilated cardiomyopathy	0.000262	0.0215	CrCbGaD
Propranolol—Esmolol—ADRB2—dilated cardiomyopathy	0.000259	0.0213	CrCbGaD
Propranolol—Nausea—Lisinopril—dilated cardiomyopathy	0.000258	0.00263	CcSEcCtD
Propranolol—Bevantolol—ADRB2—dilated cardiomyopathy	0.000256	0.0211	CrCbGaD
Propranolol—Acebutolol—ADRB1—dilated cardiomyopathy	0.000248	0.0204	CrCbGaD
Propranolol—Oxprenolol—ADRB1—dilated cardiomyopathy	0.000246	0.0203	CrCbGaD
Propranolol—Bopindolol—ADRB2—dilated cardiomyopathy	0.000237	0.0195	CrCbGaD
Propranolol—Betaxolol—ADRB2—dilated cardiomyopathy	0.000228	0.0188	CrCbGaD
Propranolol—Atenolol—ADRB2—dilated cardiomyopathy	0.000226	0.0186	CrCbGaD
Propranolol—Penbutolol—ADRB2—dilated cardiomyopathy	0.000226	0.0186	CrCbGaD
Propranolol—Alprenolol—ADRB1—dilated cardiomyopathy	0.000225	0.0185	CrCbGaD
Propranolol—Bisoprolol—ADRB2—dilated cardiomyopathy	0.00022	0.0181	CrCbGaD
Propranolol—Metoprolol—ADRB1—dilated cardiomyopathy	0.000209	0.0172	CrCbGaD
Propranolol—Acebutolol—ADRB2—dilated cardiomyopathy	0.000209	0.0172	CrCbGaD
Propranolol—Oxprenolol—ADRB2—dilated cardiomyopathy	0.000207	0.017	CrCbGaD
Propranolol—Pindolol—ADRB1—dilated cardiomyopathy	0.000194	0.0159	CrCbGaD
Propranolol—Alprenolol—ADRB2—dilated cardiomyopathy	0.000189	0.0156	CrCbGaD
Propranolol—Metoprolol—ADRB2—dilated cardiomyopathy	0.000176	0.0145	CrCbGaD
Propranolol—Pindolol—ADRB2—dilated cardiomyopathy	0.000163	0.0134	CrCbGaD
Propranolol—Propafenone—ADRB1—dilated cardiomyopathy	0.000154	0.0127	CrCbGaD
Propranolol—Carvedilol—ADRB1—dilated cardiomyopathy	0.000139	0.0114	CrCbGaD
Propranolol—Carvedilol—ADRB2—dilated cardiomyopathy	0.000117	0.00962	CrCbGaD
Propranolol—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	6.16e-05	0.00128	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	6.15e-05	0.00128	CbGpPWpGaD
Propranolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.11e-05	0.00127	CbGpPWpGaD
Propranolol—HTR1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	6.11e-05	0.00127	CbGpPWpGaD
Propranolol—ADRB3—GPCR ligand binding—AGT—dilated cardiomyopathy	6.08e-05	0.00127	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.07e-05	0.00126	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.02e-05	0.00125	CbGpPWpGaD
Propranolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	5.95e-05	0.00124	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.93e-05	0.00123	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.91e-05	0.00123	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.88e-05	0.00122	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	5.79e-05	0.00121	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	5.78e-05	0.0012	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.77e-05	0.0012	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.77e-05	0.0012	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.75e-05	0.0012	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.72e-05	0.00119	CbGpPWpGaD
Propranolol—HTR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	5.7e-05	0.00119	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.66e-05	0.00118	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.36e-05	0.00112	CbGpPWpGaD
Propranolol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	5.34e-05	0.00111	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	5.24e-05	0.00109	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	5.23e-05	0.00109	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.19e-05	0.00108	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.13e-05	0.00107	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.11e-05	0.00106	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.02e-05	0.00104	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.97e-05	0.00103	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.97e-05	0.00103	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.91e-05	0.00102	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.89e-05	0.00102	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.87e-05	0.00101	CbGpPWpGaD
Propranolol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	4.8e-05	0.001	CbGpPWpGaD
Propranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.74e-05	0.000987	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	4.74e-05	0.000985	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	4.74e-05	0.000985	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.66e-05	0.000969	CbGpPWpGaD
Propranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.64e-05	0.000965	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.63e-05	0.000964	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.62e-05	0.000962	CbGpPWpGaD
Propranolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.54e-05	0.000944	CbGpPWpGaD
Propranolol—HTR1B—GPCR ligand binding—AGT—dilated cardiomyopathy	4.53e-05	0.000943	CbGpPWpGaD
Propranolol—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	4.48e-05	0.000932	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	4.45e-05	0.000926	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.44e-05	0.000923	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.4e-05	0.000916	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	4.34e-05	0.000903	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	4.34e-05	0.000903	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.3e-05	0.000895	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.3e-05	0.000895	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.26e-05	0.000887	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.21e-05	0.000876	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	4.21e-05	0.000875	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	4.19e-05	0.000871	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	4.14e-05	0.00086	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	4.14e-05	0.00086	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.05e-05	0.000843	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4e-05	0.000832	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	3.96e-05	0.000823	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.91e-05	0.000813	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.87e-05	0.000805	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.84e-05	0.000799	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.83e-05	0.000797	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	3.79e-05	0.000788	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.77e-05	0.000785	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.77e-05	0.000785	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.69e-05	0.000767	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.69e-05	0.000767	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.64e-05	0.000758	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.61e-05	0.000751	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.61e-05	0.00075	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.61e-05	0.00075	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.6e-05	0.000749	CbGpPWpGaD
Propranolol—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	3.59e-05	0.000747	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	3.58e-05	0.000744	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	3.53e-05	0.000735	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.51e-05	0.000729	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.45e-05	0.000719	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	3.45e-05	0.000719	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	3.44e-05	0.000716	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.44e-05	0.000715	CbGpPWpGaD
Propranolol—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	3.43e-05	0.000714	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.43e-05	0.000714	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.42e-05	0.000712	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.42e-05	0.000712	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.41e-05	0.000709	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.41e-05	0.000709	CbGpPWpGaD
Propranolol—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.36e-05	0.000699	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.36e-05	0.000699	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.35e-05	0.000698	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.35e-05	0.000697	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.35e-05	0.000697	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.32e-05	0.000691	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.31e-05	0.000688	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.28e-05	0.000681	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.28e-05	0.000681	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.27e-05	0.00068	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.25e-05	0.000676	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	3.24e-05	0.000673	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.18e-05	0.000662	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.17e-05	0.000659	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3.17e-05	0.000659	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.16e-05	0.000657	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.14e-05	0.000653	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—AGT—dilated cardiomyopathy	3.12e-05	0.00065	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.11e-05	0.000648	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.07e-05	0.000638	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.05e-05	0.000634	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.02e-05	0.000628	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	2.98e-05	0.000619	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.95e-05	0.000614	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	2.93e-05	0.000609	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.9e-05	0.000603	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.86e-05	0.000595	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.86e-05	0.000594	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.84e-05	0.00059	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.77e-05	0.000577	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.75e-05	0.000572	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.69e-05	0.00056	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.68e-05	0.000558	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.68e-05	0.000558	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.63e-05	0.000548	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.63e-05	0.000547	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.62e-05	0.000545	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.58e-05	0.000536	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.56e-05	0.000533	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.54e-05	0.000528	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.54e-05	0.000528	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.54e-05	0.000528	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	2.52e-05	0.000525	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.52e-05	0.000524	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.5e-05	0.00052	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.49e-05	0.000517	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.44e-05	0.000507	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.39e-05	0.000497	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.36e-05	0.000491	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.33e-05	0.000484	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.29e-05	0.000476	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	2.28e-05	0.000475	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.28e-05	0.000474	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.23e-05	0.000464	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.18e-05	0.000454	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.18e-05	0.000453	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.17e-05	0.000451	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.14e-05	0.000445	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.14e-05	0.000444	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.12e-05	0.000442	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.09e-05	0.000435	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.07e-05	0.000431	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.04e-05	0.000425	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.04e-05	0.000425	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.02e-05	0.000421	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.02e-05	0.000421	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2e-05	0.000415	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.98e-05	0.000412	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.98e-05	0.000412	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.95e-05	0.000406	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.95e-05	0.000406	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.95e-05	0.000405	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.94e-05	0.000404	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.93e-05	0.000403	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.93e-05	0.000403	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.93e-05	0.000402	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.91e-05	0.000398	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.9e-05	0.000395	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.88e-05	0.000391	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.86e-05	0.000386	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.85e-05	0.000386	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.85e-05	0.000386	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.85e-05	0.000384	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AGT—dilated cardiomyopathy	1.84e-05	0.000384	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.84e-05	0.000383	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.81e-05	0.000377	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.8e-05	0.000374	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.79e-05	0.000371	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.78e-05	0.000371	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.77e-05	0.000369	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.76e-05	0.000366	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.74e-05	0.000362	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.74e-05	0.000362	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.74e-05	0.000362	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.66e-05	0.000345	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.61e-05	0.000336	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.59e-05	0.000331	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.57e-05	0.000326	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.56e-05	0.000324	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.52e-05	0.000317	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.49e-05	0.00031	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.49e-05	0.000309	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.48e-05	0.000307	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.44e-05	0.000299	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	1.42e-05	0.000296	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	1.42e-05	0.000296	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.41e-05	0.000294	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.39e-05	0.000289	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	1.39e-05	0.000288	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	1.38e-05	0.000288	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.37e-05	0.000286	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.35e-05	0.000282	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.29e-05	0.000268	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.28e-05	0.000266	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.27e-05	0.000264	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.26e-05	0.000262	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	1.25e-05	0.00026	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	1.25e-05	0.000259	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.24e-05	0.000258	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.23e-05	0.000256	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.22e-05	0.000254	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.21e-05	0.000252	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.15e-05	0.000238	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.12e-05	0.000233	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.11e-05	0.00023	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.1e-05	0.000228	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.09e-05	0.000228	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.07e-05	0.000223	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.05e-05	0.000218	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.03e-05	0.000214	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.01e-05	0.00021	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	1e-05	0.000208	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	9.72e-06	0.000202	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	9.54e-06	0.000198	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	9.46e-06	0.000197	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	9.02e-06	0.000188	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.82e-06	0.000183	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—EGFR—dilated cardiomyopathy	8.78e-06	0.000183	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.63e-06	0.000179	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	8.52e-06	0.000177	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.44e-06	0.000176	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	7.95e-06	0.000165	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	7.76e-06	0.000161	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	7.74e-06	0.000161	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.6e-06	0.000158	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CD36—dilated cardiomyopathy	7.56e-06	0.000157	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.43e-06	0.000155	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	7.31e-06	0.000152	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	7.27e-06	0.000151	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	7.12e-06	0.000148	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	6.97e-06	0.000145	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AGT—dilated cardiomyopathy	6.81e-06	0.000142	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.54e-06	0.000136	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	6.41e-06	0.000133	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	6.2e-06	0.000129	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	6.03e-06	0.000126	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	5.43e-06	0.000113	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.21e-06	0.000108	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	5.1e-06	0.000106	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.98e-06	0.000104	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.78e-06	9.95e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.66e-06	9.69e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.19e-06	8.72e-05	CbGpPWpGaD
